Biomedical Engineering Reference
In-Depth Information
76. Stolzing A, Scutt A (2006) Age-related impairment of mesenchymal progenitor cell function.
Aging Cell 5(3):213-224
77. Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F (2002) Reduced chondrogenic
and
adipogenic
activity
of
mesenchymal
stem
cells
from
patients
with
advanced
osteoarthritis. Arthritis Rheum 46(3):704-713
78. Zhang H, Fazel S, Tian H, Mickle DA, Weisel RD, Fujii T, Li RK (2005) Increasing donor
age adversely impacts beneficial effects of bone marrow but no smooth muscle myocardial
cell therapy. Am J Physiol Heart Circ Physiol 289(5): H2089-H2096
79. Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, Baggett LS, Mikos AG, Cao Y
(2008) Donor age and cell passage affects differentiation potential of murine bone marrow-
derived stem cells. BMC Cell Biology
http://www.biomedcentral.com/1471-2121/9/60
80.
http://ClinicalTrials.gov
website
81. Xue G, He M, Zhao J, Chen Y, Tian Y, Zhao B (2011) Intravenous umbilical cord
mesenchymal stem cell infusion for the treatment of combined malnutrition nonunion of the
humerus and radial nerve injury. Regenerative Med 6:733-741
82. Wu KH, Chan CK, Tsai C, Chang YH, Sieber M, Chiu TH, Ho M, Peng CT, Wu HP, Huang
JL (2011) Effective treatment of severe steroid-resistant acute graft-versus-host disease with
umbilical cord-derived mesenchymal stem cells. Transplantation 91(12):1412-1416
83. Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L (2009) Allogeneic mesenchymal
stem cells transplantation in treatment of multiple sclerosis. Mult Scler 15(5):644-646
84. Liang J, Gu F, Wang H, Hua B, Hou Y, Shi S, Lu L, Sun L (2010) Mesenchymal stem cell
transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 6(8):486-489
Accessed
30
Nov 2011
86.
http://www.cdc.gov/traumaticbraininjury/statistics.html
.
Accessed 30 Nov 2011
87.
http://www.cdc.gov/ncbddd/cp/data.html
. Accessed 30 Nov 30 2011